Sign In
Buy IBIO
$1.84
+0.0800 (+4.55%)
At Close: Jun 03, 2026
NEW YORK, June 24, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biologics contract manufacturing organization and biotechnology company, today announ
3 Pros, 3 Cons For Buying iBio Stock Right Now
10:16am, Thursday, 18'th Jun 2020
IBIO stock has drawn a good deal of interest of late. It's a speculative play with the potential to reward optimistic investors handsomely.
Coronavirus Hype Is Boosting iBio Shares to Unrealistic Levels
10:31am, Wednesday, 17'th Jun 2020
The enthusiasm surrounding iBio stock is warranted since the company is yet to deliver a viable, commercially successful vaccine.
IBIO Stock: Early Shareholders Can Win If iBio Gets a Vaccine Contract | InvestorPlace
04:10pm, Tuesday, 16'th Jun 2020
As companies race to develop a Covid-19 vaccine, IBIO stock investors are likely paying too much for a potential manufacturing contract.
FastPharming Tech Makes iBio Stock a Buy
03:45pm, Thursday, 11'th Jun 2020
Unlike other vaccine stocks, iBio has the tech it needs to scale up manufacturing of its candidate. That makes IBIO stock a buy here.
More Suspect PR and Now One More Reason to Walk Away From IBIO Stock
04:39pm, Wednesday, 10'th Jun 2020
For investors in search of a novel coronavirus play, IBIO’s puny capitalization and continued one-trick pony press releases are fair warning.
7 Risky Stocks That Are Worth a Gamble
07:18pm, Monday, 08'th Jun 2020
These seven A- and B-rated names are some of the top risky stocks to buy for enterprising investors. Here's what you should know about them.
For iBio, the Coronavirus Pandemic Was a Lucky Break
10:01am, Friday, 05'th Jun 2020
The novel coronavirus pandemic caught iBio (NYSE:IBIO) stock at a good time.Source: Maksim Shmeljov / Shutterstock.com The company just finished building a 130,000-square-foot facility near Texas A&M;
The Party Is Over for Moderna Stock Holders
04:15am, Friday, 05'th Jun 2020
[Editor's Note: "Sell Moderna (MRNA) Stock as Covid-19 Catalyst Inflates Valuation" was originally published April 2, 2020. It is regularly updated to include the most relevant information.]Source: Sh
iBio Announces Second COVID-19 Vaccine Program
11:00am, Thursday, 04'th Jun 2020
- IBIO-201, a subunit vaccine combining SARS-CoV-2 spike protein antigens with the Company’s proprietary LicKM booster technology, advances to preclinical immunization studies.
5 of the Best Micro-Cap Stocks to Gamble On for Big Gains
06:17pm, Monday, 01'st Jun 2020
Don't bet the ranch, but consider these five high-risk micro-cap stocks a buy, as each one has the potential for big gains.
